FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381795358> ?p ?o ?g. }

• W4381795358 endingPage "87" @default.
• W4381795358 startingPage "60" @default.
• W4381795358 abstract "Fatty acid oxidation disorders (FAODs) are a group of inherited metabolic diseases (IMDs) caused by impairments in mitochondrial β-oxidation of fatty acids (FA) due to defects in genes encoding enzymes, transporters, membrane channels, and receptors that mediate this process. A common characteristic of this group of IMDs is an energy deficit associated with suppression of energy metabolism in mitochondria due to a decrease in the production of ketone bodies and the substrate of the tricarboxylic acid cycle – acetyl-coenzyme A. Since energy deficiency is a common pathogenetic factor of the entire group of FAODs, the manifestation of these inherited diseases is similar, and only certain nosologies have specific differences in the clinical picture, accordingly, these disorders require similar treatment. Initial manifestations of FAODs in neonatal and early childhood most often include cardiomyopathy, liver dysfunction, and hypoketotic hypoglycemia. For newborns with FAOD, the main danger is rapidly progressing crisis states of metabolic decompensation with severe, often fatal consequences. In adolescence, in addition to the above severe symptoms, episodes of rhabdomyolysis may also occur.Since long intervals between meals are one of the main factors provoking episodes of metabolic decompensation in patients with FAODs, the key tool for their prevention is the avoidance of prolonged fasting. In cases of the development of metabolic crisis states, symptomatic treatment is used with the introduction of carnitine according to indications. The special role of carnitine is its involvement in the transport of long-chain fatty acids through the mitochondrial membrane. Treatment of FAODs caused by a deficiency of enzymes whose substrates are long-chain fatty acids involves the use of a low-fat diet and the addition of medium-chain triglycerides and docosahexaenoic acid to the diet. Success in treating IMDs as such and FAODs, particularly, is directly related to early detection of the disease and treatment beginning since the destructive effect of toxic metabolites on internal organs and the brain increases according to the duration of exposure, leading to their progressive damage and delay in physical and mental development.An effective tool for the early detection of newborns with IMDs is the extended neonatal screening program, the implementation of which, according to the WHO, has become the greatest achievement of the health care systems of the developed countries of the world in reducing the levels of child mortality and disability in the first 10 years of the 21st century. In 2019, the program of extended newborn screening of IMDs was started in Ukraine at the initiative of the State Institution “Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Medical Sciences of Ukraine”, “Association of Neonatologists of Ukraine” and “CDC Pharmbiotest” (Baby Screen, https://baby-screen.com.ua).One of the main reasons that limit the general use of this diagnostic procedure is doctors' lack of awareness and attention regarding IMDs, the causes of these serious diseases, diagnostic search algorithms, approaches to treatment, and patient follow-up. There is an urgent need for concise medical information that includes: a brief description of the individual genetic defect; characteristics of biochemical disorders and a list of marker substances that accumulate in the blood and urine of a newborn with IMDs; procedures of primary and clarifying laboratory studies; clinical manifestations of the disease; treatment strategy and prognosis. At the discretion of the Baby Screen team, this information is provided in the form of concise protocols.In this publication, we present eight Clinical Protocols, which were prepared by a team of specialists in metabolic pediatrics, medical genetics, and laboratory analytics, who were trained in the leading medical and genetic centers of the EU countries and regularly participate in training and scientific-practical seminars on this topic. The sources of information given in the protocols are international and national guidelines on extended neonatal screening, websites of leading organizations specializing in the diagnosis and treatment of IMDs, and well-known monographs and periodicals." @default.
• W4381795358 created "2023-06-24" @default.
• W4381795358 creator A5001958817 @default.
• W4381795358 creator A5005237072 @default.
• W4381795358 creator A5009490116 @default.
• W4381795358 creator A5013148718 @default.
• W4381795358 creator A5016792175 @default.
• W4381795358 creator A5022906299 @default.
• W4381795358 creator A5049399936 @default.
• W4381795358 creator A5049712753 @default.
• W4381795358 creator A5054810268 @default.
• W4381795358 creator A5063785418 @default.
• W4381795358 creator A5074614054 @default.
• W4381795358 creator A5080558747 @default.
• W4381795358 creator A5081029634 @default.
• W4381795358 creator A5082494169 @default.
• W4381795358 creator A5085315913 @default.
• W4381795358 creator A5092247066 @default.
• W4381795358 creator A5092247067 @default.
• W4381795358 creator A5092247068 @default.
• W4381795358 creator A5092247069 @default.
• W4381795358 date "2023-02-23" @default.
• W4381795358 modified "2023-09-27" @default.
• W4381795358 title "UPDATED CLINICAL PROTOCOLS OF INHERITED FATTY ACID OXIDATION DISORDERS IN NEWBORNS: CONSOLIDATED DATA FROM THE INTERNATIONAL CLINICAL GUIDELINES" @default.
• W4381795358 doi "https://doi.org/10.24061/2413-4260.xiii.1.47.2023.9" @default.
• W4381795358 hasPublicationYear "2023" @default.
• W4381795358 type Work @default.
• W4381795358 citedByCount "0" @default.
• W4381795358 crossrefType "journal-article" @default.
• W4381795358 hasAuthorship W4381795358A5001958817 @default.
• W4381795358 hasAuthorship W4381795358A5005237072 @default.
• W4381795358 hasAuthorship W4381795358A5009490116 @default.
• W4381795358 hasAuthorship W4381795358A5013148718 @default.
• W4381795358 hasAuthorship W4381795358A5016792175 @default.
• W4381795358 hasAuthorship W4381795358A5022906299 @default.
• W4381795358 hasAuthorship W4381795358A5049399936 @default.
• W4381795358 hasAuthorship W4381795358A5049712753 @default.
• W4381795358 hasAuthorship W4381795358A5054810268 @default.
• W4381795358 hasAuthorship W4381795358A5063785418 @default.
• W4381795358 hasAuthorship W4381795358A5074614054 @default.
• W4381795358 hasAuthorship W4381795358A5080558747 @default.
• W4381795358 hasAuthorship W4381795358A5081029634 @default.
• W4381795358 hasAuthorship W4381795358A5082494169 @default.
• W4381795358 hasAuthorship W4381795358A5085315913 @default.
• W4381795358 hasAuthorship W4381795358A5092247066 @default.
• W4381795358 hasAuthorship W4381795358A5092247067 @default.
• W4381795358 hasAuthorship W4381795358A5092247068 @default.
• W4381795358 hasAuthorship W4381795358A5092247069 @default.
• W4381795358 hasBestOaLocation W43817953581 @default.
• W4381795358 hasConcept C126322002 @default.
• W4381795358 hasConcept C134018914 @default.
• W4381795358 hasConcept C2776991927 @default.
• W4381795358 hasConcept C2777735490 @default.
• W4381795358 hasConcept C2778435403 @default.
• W4381795358 hasConcept C2778721985 @default.
• W4381795358 hasConcept C28859421 @default.
• W4381795358 hasConcept C31532488 @default.
• W4381795358 hasConcept C55493867 @default.
• W4381795358 hasConcept C62231903 @default.
• W4381795358 hasConcept C71924100 @default.
• W4381795358 hasConcept C82714985 @default.
• W4381795358 hasConcept C86803240 @default.
• W4381795358 hasConceptScore W4381795358C126322002 @default.
• W4381795358 hasConceptScore W4381795358C134018914 @default.
• W4381795358 hasConceptScore W4381795358C2776991927 @default.
• W4381795358 hasConceptScore W4381795358C2777735490 @default.
• W4381795358 hasConceptScore W4381795358C2778435403 @default.
• W4381795358 hasConceptScore W4381795358C2778721985 @default.
• W4381795358 hasConceptScore W4381795358C28859421 @default.
• W4381795358 hasConceptScore W4381795358C31532488 @default.
• W4381795358 hasConceptScore W4381795358C55493867 @default.
• W4381795358 hasConceptScore W4381795358C62231903 @default.
• W4381795358 hasConceptScore W4381795358C71924100 @default.
• W4381795358 hasConceptScore W4381795358C82714985 @default.
• W4381795358 hasConceptScore W4381795358C86803240 @default.
• W4381795358 hasIssue "1(43)" @default.
• W4381795358 hasLocation W43817953581 @default.
• W4381795358 hasOpenAccess W4381795358 @default.
• W4381795358 hasPrimaryLocation W43817953581 @default.
• W4381795358 hasRelatedWork W2060523002 @default.
• W4381795358 hasRelatedWork W2071441498 @default.
• W4381795358 hasRelatedWork W2077443482 @default.
• W4381795358 hasRelatedWork W2102326852 @default.
• W4381795358 hasRelatedWork W2134343450 @default.
• W4381795358 hasRelatedWork W2161699685 @default.
• W4381795358 hasRelatedWork W2192938660 @default.
• W4381795358 hasRelatedWork W2263304806 @default.
• W4381795358 hasRelatedWork W2510195373 @default.
• W4381795358 hasRelatedWork W76394038 @default.
• W4381795358 hasVolume "8" @default.
• W4381795358 isParatext "false" @default.
• W4381795358 isRetracted "false" @default.
• W4381795358 workType "article" @default.